Reddit Posts
DMT and psychedelic 2024 stock Recommendations?
$RGBP Must read mRNA #FDA in play!
$CYBN, $SILO, $ENVB, $MNMD-- Psychedelics and Medical Care
$CYBN, $SILO, $ENVB, $MNMD-- Psychedelics and Medical Care
$CYBN, $SILO, $ENVB, $MNMD-- Psychedelics and Medical Care
Psychedelics Medicine going Mainstream? $CYBN, $SILO,$MNMD, $ENVB
MAPS on track for potential FDA approval of MDMA therapy next year
MAPS MDMA Phase 3 MDMA-AT Study Is Published - 1st Completed Ph3 Ever For The Industry!
Psychedelic stocks? MAPS about to release MDMA Assisted Therapy PH3 trails and foresee FDA approval. Can this sector BOOM?
How to take advantage of the psychedelic medicine market? MDMA is the next big thing?
Managment overview and AMA with Pharmala Biotech ($MDMA)
MAPS - a curious ticker........
Document Claims Alameda CEO Caroline Ellison’s FTX Margin Position Was Negative $1.3B in May 2022
Putting all my life savings to buy MAPS$ calls for 2.5$ for 11/18. Any advice?
Bullish on the psychedelic sector. Possible investment strategy to capture as much value as possible. Thoughts
Bullish on the psychedelic sector. Possible investment strategy to capture as much value as possible. Thoughts
What are your Price targets after SAFE+GERMANY legalization Catalysts by Jan 23? $MSOS $TLRY
The Sad thing is the chart reads BULLISH and attention is on Ryan 🤦🏾♂️
Twitter contends that Musk breached his agreement to buy it by not using “reasonable best efforts” to close the deal, and so has no right to bail out.
Twitter contends that Musk breached his agreement to buy it by not using “reasonable best efforts” to close the deal, and so has no right to bail out.
Will the Delaware Court of Chancery Agree to Hear Twitter’s Case Against Elon Musk in November? Twitter’s lawyers are asking the Complex Commercial Litigation Division to limit discovery and trial prep to 120 days allowing the trial to commence in early November.
Seems like MJs underlying index has unofficially incorporated $LFLY - Question is how much?
Summertime With Leafly (Unofficially Starting May 4) - $LFLY 😊💃☀️🌊
$MCMJ - Can't be a low float deSPAC and is horrendously overvalued?
WeedMaps @ $4.20. Conspiracy or Fate?
$MAPS is so undervalued so I had to throw all the tendies I could, wish Robinhood gave me more margin for this 🙏 WEEDMAP$ is the Future 😮💨
$MAPS DD -- an undervalued SaaS bet on Cannabis with 100%+ upside potential
For those in weed SPACS (MCMJ / MAPS / etc.) - this is pretty big news (linked to a summary comment from WSB)
Why I am Long on WM Holdings ($MAPS) Due Dillegence Analysis
Any insight on to why MAPS is tanking post earnings?
My largest long and shorts both hit today +$18k long MAPS and +$6.6k short TSLA. Excited for more crashing of TSLA and we're just warming up for ER on Thursday for MAPS
MAPS is SaaS for weed. Shopyfy + weed = WeedMaps ?
MAPS is SaaS for weed. Shopyfy + weed = WeedMaps ?
MAPS (WM Technology Inc): Acquires Leading Cannabis CRM & Marketing Platform Sprout
Mentions
Danny Moses: You're completely sure of the CANDLES? Jared Vennett: Look at him, that's my GEOS. Mark Baum: Your what? Jared Vennett: My GEOGRAPHICALS. My MAPS specialist. Look at him, you notice anything different about him? Look at his face. Mark Baum: That's pretty racist. Jared Vennett: Look at his eyes, I'll give you a hint, his name is KOSPI. He won a national MAP competition in KOREA! HE DOESN'T EVEN SPEAK ENGLISH! Yeah I'm sure of the MAPS. Ted Jiang: [to camera] Actually, my name's KIM and I do speak English. Jared likes to say I don't because he thinks it makes me seem more authentic. And I got second in that national MAPS competition.
My monthly "under a dollar" picks: SNTI PRSO SKYE IFRX MAPS XPON And I'm currently holding: SGN RXT JTAI IBRX SEGG
Still confident about MAPS?
Anyone got thoughts on how low MAPS will go? Continues to trend down long term. MAPS WM TECHNOLOGY INC COM price $0.69 Price/Earnings 9.46x Return on equity 18.24% Gross margin 95.02% Operating margin 6.21% [https://www.cnbc.com/quotes/MAPS](https://www.cnbc.com/quotes/MAPS)
Mine is atypical so the nerve is always “on”. I had a hookup and I know the people at MAPS well enough that I was at their Burning Man camp the year I went so this was never in a medical setting. I snort a little and all the pain goes away, everything from my face to my broken back just goes quiet. It’s not something I do terribly often but it can help with both the pain and depression because escape from the pain is only a bump away. But talk to a doctor, they do have ketamine clinics now where it can be done legally.
whats up with MAPS jumping pre
I thought losing 90% of MAPS and WORK was bad
MAPS $2 calls cannabis stock for April 2026. Could be a good pop after 4 year sell off
Yeah the guy posted an entire $MAPS DD in this subreddit like a month ago. Check it out. He got shit on by most people. I said I admired his conviction and wished him the best. You don’t go all with $4 million position in one name unless you got real conviction. Heres the link: https://www.reddit.com/r/weedstocks/s/uUPvKdkjA0
There is a guy here that is holding $4 million dollars worth of MAPS
weed is just a green critical mineral ! $MAPS
I’m balls deep in $MAPS. All that data from over a decade in the weed business is worth something.
you want lagger in weed its MAPS profitable , not directly touching weed, have cash reserves of 1/2 of mrk cap . If this get signed they will thrive with their clients finally having cash
is MAPS not going to benefit from this or why is it not going up compared to everything else in the sector ???
MAPS warrants. That's all I'm saying.
MAPS rising due to weed rescheduling and one of the few that actually make money.
So MAPS is up due to weed rescheduling. This penny stock also actually makes $
Will be watching MIST and MAPS today
MAPS is having a good run, and it is one of the few penny stocks that genereates profits.
I thought, “surely this new 2020 democratic administration will correct their marijuana laws. Better buy Weedmaps (MAPS) now!”
I think I read somewhere MAPS is debt free with cash on hand, so there's very low insolvency risk. Anyways, dead capital isn't a good thing if the company's revenues keep dwindling the stock at best will meander, at worst slide off until it's selling for a bit more than cash on hand.
Doesn’t mean hes wrong yet. Long term thesis on a stock doesn’t mean it won’t drop short term. I have no conviction in MAPS but he does , and he might be right. You can’t call it yet.
>where was that guy promoting MAPS? Assuming his investment is real, he's down about $800,000 since his post.
Interesting price movement today as a few names have continued to hold up better than others....where was that guy promoting MAPS? It's taken a beating. Him and the RYM guy can battle it out for biggest and craziest bets!
MAPS is down to $0.79....we tried to warn ya...
You are so wrong in your 'thesis', and now even worse is the CONSTANT attempt to save your own ass by dragging others down with you I can only hope here that karma is gonna be a real b\*tch to ruthless \*\*\*\*s like you! ps .. or the mods ban your a$$ and stop this worthless pumping of yours DISCLAIMER to ALL .. this shill is a$$ deep in a bad investment here in MAPS and is looking for a way out. Don't let that be own your hard earned dollars
Flooding the forum with useless pump posts regarding your personal investment does nothing to add value here Anybody really buying into this guys crap needs only to scroll out on the five year chart for this POS stock called ' MAPS ' and then stay very, VERY far away
You mean declining revenue, a few thousand users and no moat? If you are so confident in your play why are you trying to pushing MAPS so hard? This thing is a turd and you have a timebomb on your hands. GTI isn’t on Weedmaps in my area and neither are the other big companies. Once a company has enough market share they don’t need WM. This company is a dog.
I don’t. In every developed cannabis market, there always ends up being an oversupply of flower. I don’t see the long term story with MSOs and producers. Green Thumb is fine, but they’re going to be eventually selling a commodity. I think MAPS has far more upside.
You're free to have your opinion on this. I have no intention of selling MAPS, and I've added about $50k today alone.
>Most cannabis stocks have already doubled since rescheduling discussions began. MAPS briefly moved higher but returned to pre-catalyst levels, making it the only remaining asymmetric opportunity in the space. It is the only cannabis stock I own for this reason. This sounds like hopium based on charts rather than actual due diligence
Weedmaps is a dead man walking. They can't advertise vapes since they are in the app store on iphone. And why not just skip the middle man and go right to the dispensary to order? I don't see MAPS as being anymore frictionless or having a better mousetrap. The only thing they have going for it is the fact that you can shop multiple stores simultaneously.
Why do I need maps though? I’m just thinking personally, If wanted to buy Cannabis at dispensary I would just open up google maps and search for the ones that are close to me. I’m just going to whichever one is nearby. I wouldn’t even know that there was this MAPS app. Thoughts?
There is a big cult following online. Graphic novels are now coming out and YouTube is full of these things called MAPS which is a project full of animators that recreate a story from the lore over a song.
Academic & Clinical Supply Contracts (by date) • Johns Hopkins University — supply of LaNeo™ MDMA; shipment completed Oct 2, 2025.  • Yale University — contracted supplier (Nov 7, 2024); shipment completed Jun 2, 2025.  • University of Washington — shipment of LaNeo™ MDMA for pilot trial (Mar 21, 2025).  • UCLA — shipment of LaNeo™ MDMA for schizophrenia study (Mar 3, 2025).  • UT Health San Antonio (STRONG STAR Consortium) — supply incl. new 20 mg dose; trial funded via U.S. DoD appropriation (Feb 27, 2025; builds on Oct 8, 2024 contract).  • Icahn School of Medicine at Mount Sinai — contracted supplier (Oct 21, 2024).  • McLean Hospital (Harvard affiliate) — contracted supplier (Oct 2, 2024).  • Johns Hopkins Medicine — sales agreement (original contract Sep 11, 2024).  • University of Texas San Antonio — contracted to develop/ supply novel dosage form (Oct 8, 2024).  • Merhavim Mental Health Centre (Israel) + MAPS Israel — data-license exchange supply (agreement Jan 20, 2025; delivery Aug 7, 2024 noted) .  • University of California (campus not specified in PR) — supply for clinical trial (Oct 5, 2022).  • Monash University (Australia) — supply to Clinical Psychedelic Lab (Apr 20, 2023; archived).  • Mind Medicine Australia & Orygen Institute — shipment of MDMA (Aug 10, 2023; archived).  • Incannex — supply of LaNeo™ MDMA & psilocybin (Apr 25, 2023; archived).  • Awakn Life Sciences — exclusive MDMA supply partner (Mar 1, 2023; archived).  Distribution / Logistics Agreements • U.S. Distributor (name not disclosed) — warehousing & distribution for U.S. clinical clients (Mar 24, 2025).  • Duchefa Farma (Netherlands) — exclusive distributor with annual minimums & QP release duties (Mar 10, 2025).  • Veridion Group (New Zealand) — exclusive distributor (Sep 25, 2025).  • CCrest Labs (Canada) — earlier distribution expansion (May 10, 2022); agreement later terminated (Oct 21, 2024 PR notes termination).  Joint Venture / Subsidiary & Australia-Specific • Cortexa Pty Ltd (JV with Vitura Health, 50:50) — Australian psychedelics JV (announced May 1–2, 2023); led first TGA AP-scheme psilocybin supply (Mar 18, 2024) and commenced GMP LaNeo™ MDMA manufacturing in Australia (Apr 5, 2024).  • PharmAla Biotech Australia Pty Ltd (wholly-owned) — incorporated to support AU clinical research/ manufacturing (Sep 3, 2025).  Other Commercial / Collaboration Items • Sale agreement with Numinus (Mar 26, 2024; archived).  • SABI Mind — MDMA supply agreement (May 19, 2022).  • Global Wellness Strategies — MDMA supply agreement (Feb 10, 2022). 
Heres a list of there current and past contracts Academic & Clinical Supply Contracts (by date) • Johns Hopkins University — supply of LaNeo™ MDMA; shipment completed Oct 2, 2025.  • Yale University — contracted supplier (Nov 7, 2024); shipment completed Jun 2, 2025.  • University of Washington — shipment of LaNeo™ MDMA for pilot trial (Mar 21, 2025).  • UCLA — shipment of LaNeo™ MDMA for schizophrenia study (Mar 3, 2025).  • UT Health San Antonio (STRONG STAR Consortium) — supply incl. new 20 mg dose; trial funded via U.S. DoD appropriation (Feb 27, 2025; builds on Oct 8, 2024 contract).  • Icahn School of Medicine at Mount Sinai — contracted supplier (Oct 21, 2024).  • McLean Hospital (Harvard affiliate) — contracted supplier (Oct 2, 2024).  • Johns Hopkins Medicine — sales agreement (original contract Sep 11, 2024).  • University of Texas San Antonio — contracted to develop/ supply novel dosage form (Oct 8, 2024).  • Merhavim Mental Health Centre (Israel) + MAPS Israel — data-license exchange supply (agreement Jan 20, 2025; delivery Aug 7, 2024 noted) .  • University of California (campus not specified in PR) — supply for clinical trial (Oct 5, 2022).  • Monash University (Australia) — supply to Clinical Psychedelic Lab (Apr 20, 2023; archived).  • Mind Medicine Australia & Orygen Institute — shipment of MDMA (Aug 10, 2023; archived).  • Incannex — supply of LaNeo™ MDMA & psilocybin (Apr 25, 2023; archived).  • Awakn Life Sciences — exclusive MDMA supply partner (Mar 1, 2023; archived).  Distribution / Logistics Agreements • U.S. Distributor (name not disclosed) — warehousing & distribution for U.S. clinical clients (Mar 24, 2025).  • Duchefa Farma (Netherlands) — exclusive distributor with annual minimums & QP release duties (Mar 10, 2025).  • Veridion Group (New Zealand) — exclusive distributor (Sep 25, 2025).  • CCrest Labs (Canada) — earlier distribution expansion (May 10, 2022); agreement later terminated (Oct 21, 2024 PR notes termination).  Joint Venture / Subsidiary & Australia-Specific • Cortexa Pty Ltd (JV with Vitura Health, 50:50) — Australian psychedelics JV (announced May 1–2, 2023); led first TGA AP-scheme psilocybin supply (Mar 18, 2024) and commenced GMP LaNeo™ MDMA manufacturing in Australia (Apr 5, 2024).  • PharmAla Biotech Australia Pty Ltd (wholly-owned) — incorporated to support AU clinical research/ manufacturing (Sep 3, 2025).  Other Commercial / Collaboration Items • Sale agreement with Numinus (Mar 26, 2024; archived).  • SABI Mind — MDMA supply agreement (May 19, 2022).  • Global Wellness Strategies — MDMA supply agreement (Feb 10, 2022). 
Have you looked at MAPS? Consistently profitable and could scale wildly in the event of rescheduling.
1. I’m not putting out a price target. I have one in mind, but it’s meaningless until rescheduling and SAFER banking actually happen. Those are the key catalysts that would make any valuation realistic. 2. MAPS’s real moat is its user base, catalog, brand partnerships, and the fact that it has the majority of dispensaries on its platform. I’ve spoken with several dispensary owners. They don’t love the fees, but they keep paying because Weedmaps drives meaningful traffic and sales. That’s why MAPS has remained profitable even while the rest of the industry is struggling.
Posting here: MAPS is the majority of my portfolio ($4 Million position). My thesis why & position in comments. Most cannabis stocks have already doubled since rescheduling chatter started. MAPS hasn’t moved. That’s what makes it interesting. It’s profitable, unaffected by 280E, and trading near pre-news levels. It’s the only asymmetric bet left in the space. --- ### 1) Setup and valuation MAPS is **listed on NASDAQ**, which brings transparency, credibility, and easier access to capital. The company has **10+ years of mostly profitable operations** and over **$50 million in cash**. It trades around **1x revenue**, a bargain for a tech marketplace. The stock is still trading near where it was *before* the recent cannabis news. Right now, the market is only pricing in **tax savings from 280E**, not the **broader industry shift** that comes with it. Lower taxes will make the legal market more competitive against the illicit market, increase marketing budgets, and drive higher transaction volumes. Meanwhile, many MSOS and growers are already **up ~2x** from a few months ago — huge downside risk if rescheduling stalls. MAPS isn’t affected by 280E, which makes it an **asymmetric bet**: limited downside, real upside. --- ### 2) Distribution, marketplace, and delivery moat **Flower is a commodity** with razor-thin margins. The value is in **distribution**, and MAPS dominates it, especially now that **Leafly is near insolvency**. MAPS is a **tech marketplace that hosts most of the dispensaries in the country** and connects them to a large **active user base** of consumers searching for legal cannabis. It’s the main discovery and advertising platform for the entire industry. Weedmaps also **lists independent, licensed delivery services** and aggregates demand, making it the **primary channel** for legal delivery. No state allows independent contractors to deliver marijuana. Only **W2 dispensary employees** or licensed mobile dispensaries can do it legally. DoorDash has added a few hemp products, but the concentrations are weak and mostly synthetic. Unless cannabis is fully descheduled, **gig delivery apps won’t be allowed** to deliver a Schedule 3 drug. --- ### 3) Rescheduling and 280E If rescheduling removes 280E, **MAPS becomes a deductible marketing expense** for clients. That means better margins for clients and higher ad and platform spending for MAPS. --- ### 4) SAFE or SAFER banking and payments optionality If banking reform passes, MAPS can start taking **commissions on billions in platform transactions**. With some quick napkin math: - Assume a **5% take rate** on platform sales - That’s roughly **$1.60 per share** in additional value Dispensaries are independently owned and generally **don’t have their own apps or payment systems**, so MAPS is perfectly positioned to handle transactions directly. --- ### 5) Hemp and illicit market enforcement If **hemp synthetics are banned**, consumers will move back to legal, regulated cannabis — directly benefiting MAPS. Enforcement is already ramping up against illegal grows and unregulated hemp operations, especially those tied to **Chinese ownership**. - Video on this topic: https://www.youtube.com/live/Tw23WzVR51U?si=ilBbdZPDkiXyenz1 - Heritage Foundation report: https://www.heritage.org/china/report/invasion-the-homeland-how-illegal-chinese-owned-marijuana-farms-have-consumed-rural Even conservative groups are now **pro-regulation** and calling for federal crackdowns. That shift favors compliant, established platforms like MAPS. --- ### 6) Insider alignment and incentives Founder CEO **Doug Francis** and **Justin Hartfield** have **never sold shares**. Doug also restructured his comp plan to take **less cash and more stock**, and it **pays out if the stock doubles or quadruples**, serious alignment with shareholders. --- ### 7) Product experience I use the app personally and think it’s great. The product works and has real-world stickiness. --- ### Risks 1. If **hemp completely takes over** and cannabis becomes easier to access than alcohol (which would require full descheduling), MAPS’s edge weakens. 2. If **rescheduling stalls** and the entire industry keeps bleeding, MAPS could struggle alongside everyone else. --- My opinion only. Not investment advice.
Didn't see your post, but I like MAPS a lot. Very impressive cash generation over the past 1-2 years. My only issue is their lower guidance for the current quarter, and the co-founders pulling their buyout offer (at what seemed to be a very reasonable price).
$MAPS back on uptrend. $SOND a hidden gem.
Lol. There are plenty of ways to make money in the market. Swing trade. Options trading. Not to just invest and bag hold. Profit off SOND since bottom. NCNA burned me on RS. In at bottom so in range of break even profit. Favor of MAPS pullback cannabis sector is quiet.
Which companies are you buying? What do you think about MAPS? Seems to be a very cheaply valued SaaS cannabis company!
$MAPS slowly coming back 😃...riding $MSOS.
Holding ProStar Holdings MAPFF on OTC (MAPS on TSX Venture) for long term.
I wonder if $MAPS works in Europe?
There’s an abnormal amount of pre-market volume for $MAPS. Someone bought 200k shares.
Anybody thinking we will get some good weed market news for things like MAPS, TLRY, or UGRO?
1. SNDL 2. TLRY 3. MSOS 4. MAPS 5. MSOX for shits and giggles
I've been holding MAPS for a while now, up 48% as of today, my only weed related holding that's been in the green for the majority of the time I've held it.
I was curious as well and this is what I found: [September 2025- Colorado DOT renewal](https://money.tmx.com/en/quote/MAPS/news) [April 2025-Radiodetection Strategy](https://money.tmx.com/en/quote/MAPS/news) [August 2025-JAVAD Distribution Deal](https://finance.yahoo.com/news/prostar-javad-gnss-announce-worldwide-120000913.html) [July 2024-New Clients Announcement](https://finance.yahoo.com/news/prostar-announces-record-revenue-q2-120000469.html)
I don't get a lot of chips to play with for good reason, but my strategy has been to buy 100 shares of stocks like these every week. I am targeting flatliners that are in the dollar price area, many have popped well for me - CISO, OCGN, PROK, URG, SMTK, LEXX, CTMX, OPEN, MAPS, DVLT, URG. Open especially, what I would have given to go all in back in June when it caught my eye around .50 a share
Look at stocks between $1-2, good market cap, trade volume and relatively stable PE ratio. Tons of those stocks are hitting for me rn, PROK, CISO, RMCO, MAPS, CTMX. I flipped to a strategy of targeting stocks that I think are undervalued and in prime manipulation territory. OPEN caught my eye at .50 in June as part of this strategy.
I heard someone mentioned MAPS before
NIO, DTST, DOUG, BITF → all have clear reasons analysts and traders still watch them. If you want squeeze/meme potential → OPEN, AMC, MAPS. If you want moonshots → STIM, CURI.
I don’t normally make calls but wanna give it a shot for next week. All these plays are under $5: NIO, DTST, DOUG, BITF → all have clear reasons analysts and traders still watch them. If you want squeeze/meme potential → OPEN, AMC, MAPS. If you want moonshots → WKSR, CURI. Looking for feedback.
$MAPSW $MAPS stacking... https://preview.redd.it/h4awpuan4umf1.png?width=1080&format=png&auto=webp&s=2dda8723cc380f229bd5f796301ee685bab42e8a
MSOS TLRY MAPS in that order - shut up and buy. I don't want to hear about how ur stupid ass got bagged 4 years ago, thats a YOU problem
Did u buy weedstocks top in 2021, regard? Is that why u crying in my mentions? Its okay, go back to flipping my burger. I only want WINNERS in the boat with me. MSOS TLRY MAPS
Anyone here have $MAPS on their radar?
MAPS/MAPSW stock and warrants gradually increasing. This is good. This is healthy. This is bullish. Gem play. Get in. 🤑🤑🤑
I've mostly done great, and still own most of what I initially invested this year (i.e. took some profits, but not too heavily). My only mistake has been in buying MAPS - This one just doesn't seem to want to go up lately, even when MSOS is doing well.
Any thoughts on MAPS? I've always been impressed by their cash generation, and how they've been able to grow their cashpile over the past few years. I'm guessing that guidance wasn't good for next quarter, but they seem like they could be an under the radar pick if S3 happens, as the MSO's will have more cash to spend on advertising.
Blackrock and Vanguard are invested in $MAPS.
What a week! HGRAF, TNXP, NVNI, MAPS. Ready to reload for next week - hoping to see some pops from PHHRF, WKSP & RZLV
First of all, and this **is** financial advice, sell your Intel stock and just buy more Google. The opportunity cost of your money doing absolutely nothing while *hoping* for an Intel comeback will have accumulated value holding Google instead Now for the NFA, I'd stay the hell away from cannabis stocks if you're building a portfolio and not trading like most people here. If I absolutely had to recommend one, I'd recommend MAPS (Weedmaps) because it's the only cannabis company that's actually net profitable
Same thing. I was able to buy 500 shares of $MAPS in the mid nineties and sold at $1.15. Made a quickie.
Great win! Do not sell anything, this shit is all about to blow up. I snuck into MAPS at .97 cents average, just 700 shares but that sucker goes to $20+ on the wave if the powers that be reschedule.
MAPS. Low float, software margins. I'm loading up options.
I got pretty lucky entering MAPS right before Q2 earnings thinking it'd be a catalyst... it was a 5th net profitable quarter in a row, with additional cash consolidation and still no debt. The stock price reaction was a nothing-burger but I figured I'd hold since there doesn't seem to be much downside, and was pleasantly surprised with the catalyst over the weekend With today's catalyst I decided to pick up even more (granted I'm playing with house money). IMO it's the best cannabis-related play for those like me with a more conservative risk profile. I believe it's the only **net** profitable cannabis stock out there (please correct me if I'm wrong) with zero debt and healthy cash pile. The net profitability limits downside risk and the zero debt with cash on-hand leaves them in a position to immediately ramp up if there's major relaxation in policy. On the other hand, MAPS is a pretty mature company so I don't think this is some "10X bagger" opportunity but I'd say an interesting one to hold at the very least.
Weedmaps is up this morning 📈 $MAPS. I'll continue to snag warrants. 😲😎
Did anyone here go to Q2 MAPS call? Thoughts?
Let's see what $NCNA brings this TGIF. Positive results for $MAPS ER
$MAPS $MAPSW 🙃 https://www.businesswire.com/news/home/20250807282733/en/WM-Technology-Inc.-Reports-Financial-Results-For-Second-Quarter-2025?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork
MAPS ER: [https://ir.weedmaps.com/news-releases/news-release-details/wm-technology-inc-reports-financial-results-second-quarter-2025](https://ir.weedmaps.com/news-releases/news-release-details/wm-technology-inc-reports-financial-results-second-quarter-2025)
For all the madness that's happening today, here's a chill stock I'm watching that's reporting earnings today - $MAPS Nothing crazy to see here, no short squeeze, no crazy pump and dump swings (as far as I can see), no overseas weirdness. Just a boring penny stock with probably very limited upside and downside risk :)
$MAPS $MAPSW warrants. Earnings AH tommorow 🙃😁
$MAPS $MAPSW earnings Friday AH via Webcast.
I just spent some time researching each of these and I think they’re all pretty good. I probably pass on CURI as it seems a little overvalued and I’m not sure about their moat. WKSP, MAPS and WDH all seem like really good picks tho…
MAPS is ProStar Holdings or WM Tech?
$MAPS $MAPSW stacking the warrants. 🤑 WeedMaps ER Aug. 7th 2025 https://preview.redd.it/i1vqmaiou7ff1.png?width=1067&format=png&auto=webp&s=785a9282ca045e743afa20904e833864fae43d28
alright since we are back on the meme train, lets talk about a small cap that was squeezed like some ripe oranges. sitting at 146m market cap and right at $1 currently a share. one of the most useless apps and websites available to degenerates like us… MAPS needs to be put on the map! I have zero DD why this should squeeze but we all have seen the shit that has been going down lately. I plan on buying a hefty share in the AM and maybe calls if available just for shits & giggles.
$MAPS $MAPSW https://preview.redd.it/sso7wg5ibhef1.jpeg?width=1654&format=pjpg&auto=webp&s=8272437c85d7b3b6e50e4f06d0776740a36c5cc8
Still stacking $MAPS and warrants... DEA MEMO VOTE MONDAY 21st, 2025 at 5:30PM
Swing $MAPS. Cheap warrants $MAPSW
$MAPS - $MAPSW 📈 WeedMaps on uptrend since it's higher low .869 broke 1.00 tapped 1.05 Cheapest warrants on NASDAQ. Cannabis is coming...
$MAPS seems undervalued...cheap warrants. Technology. Could benefit if cannabis starts trending...